Retraction Retraction dated 2020-11-05
Click to view Retraction: https://doi.org/10.1186/s13046-020-01746-0
-
Authors
Yan, Huan
Li, Hong
Li, Pengyun
Li, Xia
Lin, Jianjian
Zhu, Linlin
Silva, Maria A.
Wang, Xiaofang
Wang, Ping
Zhang, Zhan
-
Funding
Funding for this research was provided by:
Henan medical science and technology research project (201702105)
University Key Project of Henan Province (15A320064)
- License Information
-
More Information
Article History
Received: 16 August 2018
Accepted: 18 September 2018
First Online: 24 September 2018
Change Date: 5 November 2020
Change Type: Correction
Change Details: This article has been retracted. Please see the Retraction Notice for more detail:
Change Details: https://doi.org/10.1186/s13046-020-01746-0
Change Details: .
Ethics approval and consent to participate
: This human ovarian cancer sample study and in vivo study are ethically approval by the Clinical Research Ethics Committee of the Zhengzhou University (No. 2015–158) and Institutional Committee for Animal Research of Zhengzhou University.
: Consent for publication the clinical and pathological data were obtained from all the patients that involved in this study.
: The authors declare that they have no competing interests.
: Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
